147 related articles for article (PubMed ID: 29749571)
21. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype.
Malhotra R; Mauer AC; Lino Cardenas CL; Guo X; Yao J; Zhang X; Wunderer F; Smith AV; Wong Q; Pechlivanis S; Hwang SJ; Wang J; Lu L; Nicholson CJ; Shelton G; Buswell MD; Barnes HJ; Sigurslid HH; Slocum C; Rourke CO; Rhee DK; Bagchi A; Nigwekar SU; Buys ES; Campbell CY; Harris T; Budoff M; Criqui MH; Rotter JI; Johnson AD; Song C; Franceschini N; Debette S; Hoffmann U; Kälsch H; Nöthen MM; Sigurdsson S; Freedman BI; Bowden DW; Jöckel KH; Moebus S; Erbel R; Feitosa MF; Gudnason V; Thanassoulis G; Zapol WM; Lindsay ME; Bloch DB; Post WS; O'Donnell CJ
Nat Genet; 2019 Nov; 51(11):1580-1587. PubMed ID: 31659325
[TBL] [Abstract][Full Text] [Related]
22. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ;
JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681
[TBL] [Abstract][Full Text] [Related]
23. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.
Kahl S; Gancheva S; Straßburger K; Herder C; Machann J; Katsuyama H; Kabisch S; Henkel E; Kopf S; Lagerpusch M; Kantartzis K; Kupriyanova Y; Markgraf D; van Gemert T; Knebel B; Wolkersdorfer MF; Kuss O; Hwang JH; Bornstein SR; Kasperk C; Stefan N; Pfeiffer A; Birkenfeld AL; Roden M
Diabetes Care; 2020 Feb; 43(2):298-305. PubMed ID: 31540903
[TBL] [Abstract][Full Text] [Related]
24. Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease.
Dallio M; Diano N; Masarone M; Gravina AG; Patanè V; Romeo M; Di Sarno R; Errico S; Nicolucci C; Abenavoli L; Scarpellini E; Boccuto L; Persico M; Loguercio C; Federico A
Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31466361
[TBL] [Abstract][Full Text] [Related]
25. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.
Davidson JA; Desouza C; Fonseca V; Frias JP; Van Gaal L; Giorgino F; Chao J; Dex TA; Roberts M; Saremi A; Leiter LA
Diabet Med; 2020 Feb; 37(2):256-266. PubMed ID: 31365765
[TBL] [Abstract][Full Text] [Related]
26. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC; Colhoun HM; Dagenais GR; Diaz R; Lakshmanan M; Pais P; Probstfield J; Riesmeyer JS; Riddle MC; Rydén L; Xavier D; Atisso CM; Dyal L; Hall S; Rao-Melacini P; Wong G; Avezum A; Basile J; Chung N; Conget I; Cushman WC; Franek E; Hancu N; Hanefeld M; Holt S; Jansky P; Keltai M; Lanas F; Leiter LA; Lopez-Jaramillo P; Cardona Munoz EG; Pirags V; Pogosova N; Raubenheimer PJ; Shaw JE; Sheu WH; Temelkova-Kurktschiev T;
Lancet; 2019 Jul; 394(10193):121-130. PubMed ID: 31189511
[TBL] [Abstract][Full Text] [Related]
27. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
Sarin SK; Choudhury A; Sharma MK; Maiwall R; Al Mahtab M; Rahman S; Saigal S; Saraf N; Soin AS; Devarbhavi H; Kim DJ; Dhiman RK; Duseja A; Taneja S; Eapen CE; Goel A; Ning Q; Chen T; Ma K; Duan Z; Yu C; Treeprasertsuk S; Hamid SS; Butt AS; Jafri W; Shukla A; Saraswat V; Tan SS; Sood A; Midha V; Goyal O; Ghazinyan H; Arora A; Hu J; Sahu M; Rao PN; Lee GH; Lim SG; Lesmana LA; Lesmana CR; Shah S; Prasad VGM; Payawal DA; Abbas Z; Dokmeci AK; Sollano JD; Carpio G; Shresta A; Lau GK; Fazal Karim M; Shiha G; Gani R; Kalista KF; Yuen MF; Alam S; Khanna R; Sood V; Lal BB; Pamecha V; Jindal A; Rajan V; Arora V; Yokosuka O; Niriella MA; Li H; Qi X; Tanaka A; Mochida S; Chaudhuri DR; Gane E; Win KM; Chen WT; Rela M; Kapoor D; Rastogi A; Kale P; Rastogi A; Sharma CB; Bajpai M; Singh V; Premkumar M; Maharashi S; Olithselvan A; Philips CA; Srivastava A; Yachha SK; Wani ZA; Thapa BR; Saraya A; Shalimar ; Kumar A; Wadhawan M; Gupta S; Madan K; Sakhuja P; Vij V; Sharma BC; Garg H; Garg V; Kalal C; Anand L; Vyas T; Mathur RP; Kumar G; Jain P; Pasupuleti SSR; Chawla YK; Chowdhury A; Alam S; Song DS; Yang JM; Yoon EL;
Hepatol Int; 2019 Jul; 13(4):353-390. PubMed ID: 31172417
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week open-label, multicenter, post-marketing clinical study.
Terauchi Y; Fujiwara H; Kurihara Y; Suganami H; Tamura M; Senda M; Gunji R; Kaku K
J Diabetes Investig; 2019 Nov; 10(6):1518-1526. PubMed ID: 31033218
[TBL] [Abstract][Full Text] [Related]
29. [Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Lechleitner M; Clodi M; Abrahamian H; Brath H; Brix J; Drexel H; Fasching P; Föger B; Francesconi C; Fröhlich-Reiterer E; Harreiter J; Hofer SE; Hoppichler F; Huber J; Kaser S; Kautzky-Willer A; Ludvik B; Luger A; Mader JK; Paulweber B; Pieber T; Prager R; Rami-Merhar B; Resl M; Riedl M; Roden M; Saely CH; Schelkshorn C; Schernthaner G; Sourij H; Stechemesser L; Stingl H; Toplak H; Wascher TC; Weitgasser R; Winhofer-Stöckl Y; Zlamal-Fortunat S
Wien Klin Wochenschr; 2019 May; 131(Suppl 1):39-46. PubMed ID: 30980147
[TBL] [Abstract][Full Text] [Related]
30. Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study.
Kytömaa S; Hegde S; Claggett B; Udell JA; Rosamond W; Temte J; Nichol K; Wright JD; Solomon SD; Vardeny O
JAMA Cardiol; 2019 Apr; 4(4):363-369. PubMed ID: 30916717
[TBL] [Abstract][Full Text] [Related]
31. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Danne T; Garg S; Peters AL; Buse JB; Mathieu C; Pettus JH; Alexander CM; Battelino T; Ampudia-Blasco FJ; Bode BW; Cariou B; Close KL; Dandona P; Dutta S; Ferrannini E; Fourlanos S; Grunberger G; Heller SR; Henry RR; Kurian MJ; Kushner JA; Oron T; Parkin CG; Pieber TR; Rodbard HW; Schatz D; Skyler JS; Tamborlane WV; Yokote K; Phillip M
Diabetes Care; 2019 Jun; 42(6):1147-1154. PubMed ID: 30728224
[TBL] [Abstract][Full Text] [Related]
32. Identifying solutions to psychological insulin resistance: An international study.
Polonsky WH; Fisher L; Hessler D; Stuckey H; Snoek FJ; Tang T; Hermanns N; Mundet X; Silva M; Sturt J; Okazaki K; Hadjiyianni I; Cao D; Ivanova J; Desai U; Perez-Nieves M
J Diabetes Complications; 2019 Apr; 33(4):307-314. PubMed ID: 30709604
[TBL] [Abstract][Full Text] [Related]
33. First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.
Cousminer DL; Ahlqvist E; Mishra R; Andersen MK; Chesi A; Hawa MI; Davis A; Hodge KM; Bradfield JP; Zhou K; Guy VC; Åkerlund M; Wod M; Fritsche LG; Vestergaard H; Snyder J; Højlund K; Linneberg A; Käräjämäki A; Brandslund I; Kim CE; Witte D; Sørgjerd EP; Brillon DJ; Pedersen O; Beck-Nielsen H; Grarup N; Pratley RE; Rickels MR; Vella A; Ovalle F; Melander O; Harris RI; Varvel S; Grill VER; ; Hakonarson H; Froguel P; Lonsdale JT; Mauricio D; Schloot NC; Khunti K; Greenbaum CJ; Åsvold BO; Yderstræde KB; Pearson ER; Schwartz S; Voight BF; Hansen T; Tuomi T; Boehm BO; Groop L; Leslie RD; Grant SFA
Diabetes Care; 2018 Nov; 41(11):2396-2403. PubMed ID: 30254083
[TBL] [Abstract][Full Text] [Related]
34. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi Z; Tacke F; Arrese M; Chander Sharma B; Mostafa I; Bugianesi E; Wai-Sun Wong V; Yilmaz Y; George J; Fan J; Vos MB
Hepatology; 2019 Jun; 69(6):2672-2682. PubMed ID: 30179269
[TBL] [Abstract][Full Text] [Related]
35. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Strnad P; Buch S; Hamesch K; Fischer J; Rosendahl J; Schmelz R; Brueckner S; Brosch M; Heimes CV; Woditsch V; Scholten D; Nischalke HD; Janciauskiene S; Mandorfer M; Trauner M; Way MJ; McQuillin A; Reichert MC; Krawczyk M; Casper M; Lammert F; Braun F; von Schönfels W; Hinz S; Burmeister G; Hellerbrand C; Teufel A; Feldman A; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Ridinger M; Wodarz N; Soyka M; Rietschel M; Kiefer F; Weber T; Marhenke S; Vogel A; Hinrichsen H; Canbay A; Schlattjan M; Sosnowsky K; Sarrazin C; von Felden J; Geier A; Deltenre P; Sipos B; Schafmayer C; Nothnagel M; Aigner E; Datz C; Stickel F; Morgan MY; Hampe J; Berg T; Trautwein C
Gut; 2019 Jun; 68(6):1099-1107. PubMed ID: 30068662
[TBL] [Abstract][Full Text] [Related]
36. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
[TBL] [Abstract][Full Text] [Related]
37. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
[TBL] [Abstract][Full Text] [Related]
38. Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network.
Reardon CA; Lingaraju A; Schoenfelt KQ; Zhou G; Cui C; Jacobs-El H; Babenko I; Hoofnagle A; Czyz D; Shuman H; Vaisar T; Becker L
Cell Rep; 2018 Jun; 23(10):3021-3030. PubMed ID: 29874587
[TBL] [Abstract][Full Text] [Related]
39. Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.
Le MH; Le DM; Baez TC; Wu Y; Ito T; Lee EY; Lee K; Stave CD; Henry L; Barnett SD; Cheung R; Nguyen MH
J Hepatol; 2023 Aug; 79(2):287-295. PubMed ID: 37040843
[TBL] [Abstract][Full Text] [Related]
40. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
Riazi K; Azhari H; Charette JH; Underwood FE; King JA; Afshar EE; Swain MG; Congly SE; Kaplan GG; Shaheen AA
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):851-861. PubMed ID: 35798021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
